Keiretsu Forum

Keiretsu Forum, established in 2000, is an international association of private investors, business leaders, and entrepreneurs. With over 2,500 members across 50 global chapters, it facilitates networking and investment opportunities in high-growth potential companies. Members typically invest between $200,000 and $3.5 million in diverse sectors such as technology, healthcare, consumer products, and clean tech. Keiretsu Forum operates in the United States, Europe, China, and India, with chapters in major cities and regions.

Denny Kurien

Chapter President and CEO, Delhi-NCR and Bangalore

Daniel Tang

Entrepreneur Director

Jun Ueki

Managing Partner, Japan

Ira Wallace

CEO, CTO, President and Chairman

Duygu Eren

Partner and Board Member

Past deals in Washington

Inmedix

Venture Round in 2021
Inmedix, LLC is a company focused on developing diagnostics and therapeutics for autoimmune diseases by assessing and optimizing the autonomic nervous system's (ANS) control of stress responses in the brain. Founded in 2006 and located in Normandy Park, Washington, Inmedix has introduced a novel class of diagnostics and therapeutics aimed at understanding the relationship between ANS stress and autoimmune conditions. This approach, termed Immuno-autonomics, seeks to mitigate the exacerbating effects of stress on autoimmune diseases, enhancing the efficacy of existing therapies. Inmedix offers a cloud-based software platform along with diagnostic devices that track the interaction between stress and immune function, providing valuable insights for clinicians and opportunities in drug discovery.

Vita Inclinata

Series B in 2020
Vita Inclinata Technologies, Inc. is an aerospace company founded in 2019 and headquartered in Broomfield, Colorado, with additional offices in Seattle, Washington, and Estonia. The company specializes in developing autonomous systems for helicopter hoisting and sling load operations, focusing on enhancing safety and precision during these critical missions. Its flagship product is a rescue hoisting system that utilizes a proprietary control algorithm integrated into the helicopter's stabilization computer. This technology effectively mitigates the swinging motion of the hoist cable and basket, allowing for smoother and safer patient extractions and other load operations. Vita Inclinata serves a range of industries, including aerospace and construction, providing innovative solutions to improve operational efficiency and safety in challenging environments.

KitoTech Medical

Convertible Note in 2020
KitoTech Medical is a medical device company based in Seattle, Washington, focused on developing and commercializing innovative products for wound closure and care. The company's flagship product, microMend, features a unique design that incorporates tiny Microstaples on an adhesive backing, resembling a butterfly bandage. This product is painless to apply and offers the holding strength of traditional sutures, making it suitable for closing surgical incisions and lacerations. Clinical studies indicate that microMend outperforms sutures in various clinical outcomes, including cosmetic results, and can be applied more quickly by a range of medical personnel, resulting in significant cost savings. microMend is marketed across numerous surgical specialties, as well as in dermatology and emergency medicine, with additional commercialization efforts targeting military applications. The potential market for microMend is substantial, estimated at over $600 million in the U.S. and around $2 billion globally. KitoTech Medical was founded in 2011.

HaptX

Series A in 2019
HaptX develops advanced virtual reality gloves that simulate touch sensation with remarkable realism. By utilizing patented microfluidic technology, HaptX Gloves offer 130 points of touch feedback and provide resistive force feedback of 4 lbs. per finger while tracking hand motions with sub-millimeter precision. This innovative device creates a haptic experience that allows users to perceive the texture, shape, motion, vibration, and temperature of virtual objects, enhancing interaction within the virtual environment. Founded by Jake Rubin and Dr. Bob Crockett, HaptX operates with a team of 35 employees across offices in Seattle, Washington, and San Luis Obispo, California.

OtoNexus Medical Technologies

Private Equity Round in 2019
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Ecellix

Venture Round in 2019
Ecellix focuses on providing innovative battery anode materials that aim to replace traditional graphite in lithium-ion batteries. Founded in 2018 and based in Seattle, Washington, the company has developed its eCell™ technology, which incorporates a high silicon content to significantly enhance anode capacity—offering more than three times the capacity of standard graphite anodes. This technology also features exceptional retention capabilities, surpassing industry standards with the potential for thousands of cycles. Additionally, Ecellix’s single-step fabrication process allows for adjustable pore sizes, which can be tailored to optimize energy density and power. By addressing the production challenges associated with high-silicon materials, Ecellix provides battery manufacturers with a solution that improves retention capacity and energy density while reducing manufacturing costs and production times.

Precision Image Analysis

Venture Round in 2019
Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

Pattern Computer

Venture Round in 2019
Pattern Computer, Inc. is a pattern discovery company based in Friday Harbor, Washington, that specializes in uncovering insights from complex datasets. Founded in 2016, the company has developed a proprietary system that generates hypotheses and insights, enabling clients to tackle challenging problems in fields such as medical research and business analytics. Its platform is particularly noted for its application in breast cancer prognostics and the differentiation of healthy and disease-state pathways in microbiome and human gut disorders. By utilizing advanced techniques that surpass conventional methods, Pattern Computer aims to reveal novel patterns that can drive innovation and improve industry standards.

Vita Inclinata

Seed Round in 2018
Vita Inclinata Technologies, Inc. is an aerospace company founded in 2019 and headquartered in Broomfield, Colorado, with additional offices in Seattle, Washington, and Estonia. The company specializes in developing autonomous systems for helicopter hoisting and sling load operations, focusing on enhancing safety and precision during these critical missions. Its flagship product is a rescue hoisting system that utilizes a proprietary control algorithm integrated into the helicopter's stabilization computer. This technology effectively mitigates the swinging motion of the hoist cable and basket, allowing for smoother and safer patient extractions and other load operations. Vita Inclinata serves a range of industries, including aerospace and construction, providing innovative solutions to improve operational efficiency and safety in challenging environments.

Kineta

Venture Round in 2018
Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

OtoNexus Medical Technologies

Convertible Note in 2018
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

StormSensor

Seed Round in 2018
StormSensor, Inc. is a company based in Seattle, Washington, that specializes in stormwater management solutions aimed at tracking and preventing flooding, sewage overflows, and other stormwater issues. Founded in 2015, it develops Scute sensors that provide real-time monitoring of stormwater systems. Additionally, StormSensor offers Terrapin, a cloud-based software platform that allows users to visualize data on maps and time-series, correlate it with real-time weather information, and receive alerts for significant flow events. This system automates workflow for inspections, data monitoring, and regulatory reporting, thereby helping clients streamline compliance processes in a complex regulatory environment. By providing critical insights into urban flooding, illicit discharges, and the impacts of climate change, StormSensor enables its clients to respond effectively to climate-driven risks and make informed decisions regarding infrastructure maintenance and improvements.

Textile-Based Delivery

Venture Round in 2017
Textile-Based Delivery, Inc., operating under the name Nufabrx, specializes in the development and manufacturing of fabrics embedded with medications and therapeutic substances. The company offers a range of products, including bamboo pillowcases infused with tea tree oil and lavender that release these ingredients during sleep. Its innovative approach extends to various textile applications, such as headbands, wristbands, socks, shirts, shorts, underwear, shoes, leggings, athletic apparel, and swimwear. Nufabrx utilizes five patent-pending technologies that facilitate the secure and controlled release of essential oils, vitamins, and cosmeceuticals over extended periods, even enduring numerous laundering cycles. Founded in 2011, the company is headquartered in Seattle, Washington, with an additional office in Minneapolis, Minnesota.

Blaze Bioscience

Series B in 2017
Blaze Bioscience, Inc. is a biotechnology company based in Seattle, Washington, focused on developing innovative products to assist surgeons in treating cancer patients. The company specializes in tumor paint technology, which enhances real-time visualization of cancer cells during surgery. Its lead product candidate, BLZ-100, combines a targeting peptide with a fluorescent dye that emits near-infrared light, facilitating the identification and precise resection of tumors across various solid tumor types, including brain, breast, prostate, lung, colorectal, skin, and sarcoma cancers. Founded in 2010, Blaze Bioscience aims to improve surgical outcomes by enabling better detection of cancerous tissues while preserving surrounding healthy tissue.

Novuson

Convertible Note in 2017
Novuson, Inc. is a medical technology company based in Bothell, Washington, specializing in the development of ultrasonic surgical devices. Founded in 2014 as a spinout from the University of Washington’s Applied Physics Laboratory, Novuson focuses on its Direct Therapeutic Ultrasound (DTU) technology platform, which is designed to provide coagulation and hemostatic control during surgical and trauma procedures. The company’s product lineup includes an ultrasonic clamp, a beam ablation/cauterization probe, and a precision beam ultrasonic scalpel, all of which enable clinicians to treat or remove tumors and manage bleeding in solid organs and highly vascularized tissues effectively. By utilizing focused ultrasound energy, Novuson’s devices facilitate rapid hemostasis, cauterization, and division, thereby reducing operational costs and enhancing patient outcomes while minimizing complications related to bleeding.

ActX

Venture Round in 2017
ActX, Inc. is a company based in Seattle, Washington, founded in 2012, that specializes in integrating genomic information into clinical practice. The company focuses on providing actionable clinical insights derived from patients' genetic data, which helps healthcare providers personalize medical care. ActX offers services that include the collection and analysis of saliva samples, ensuring that genetic information is securely stored and privately managed. This enables physicians to access relevant genomic insights either through electronic medical records or a secure online platform, thereby enhancing patient care and improving health outcomes.

Resonance AI

Seed Round in 2016
Resonance AI is a company that specializes in artificial intelligence and analytics, focusing on video content analysis. Founded in 2013 and headquartered in Seattle, Washington, the company has developed a platform that utilizes machine learning to dissect various elements of videos, including dialogue and music. This technology enables Resonance AI to provide insights into audience engagement and preferences, helping businesses understand the connection between their content and viewer behaviors. The platform is adaptable to different types of video content, such as TV shows, trailers, and advertisements, allowing companies to make informed decisions that can enhance viewer engagement, subscriptions, and sales.

Aqueduct Critical Care

Series A in 2016
Aqueduct Critical Care, founded in 2013 and based in Bothell, Washington, focuses on developing medical devices aimed at improving the management of inter-cranial pressure (ICP) in patients with neurological diseases related to cerebral spinal fluid. The company's innovative devices utilize gravity-based drainage systems to automate the regulation of ICP, reducing the need for constant manual monitoring and adjustments. This advancement not only enhances patient mobility but also allows hospital staff to conduct necessary tests and physical therapy with minimal intervention, thereby optimizing care and reducing the demands on nursing resources.

Pyatt Broadmark

Venture Round in 2016
Pyatt Broadmark Management is based in Seattle and offers private loans for real estate financing in Washington, Oregon and Idaho. Pyatt Broadmark Management has proven to be a valuable resource for builders, ‘fix and flip’ investment buyers and developers who require quick closings, “outside the box thinking” and the utmost professional service. At Pyatt Broadmark Management, they develop trust with their borrowers based on communication, careful underwriting and fair pricing. That is why they experience so much repeat business and long-term relationships with borrowers. Whether financing single-family homes, tracts of homes or commercial real estate, their experience and personal approach allow us to respond quickly to client needs, and resolve the issues that inevitably arise in real estate development. From initial financing through project completion, Pyatt Broadmark works alongside clients to ensure their success. Whether negotiating with a third-party lender, ensuring adequate reserves for maintenance and repairs, or addressing environmental concerns, they will be your advocate throughout the process.

Monitor Mask

Series A in 2015
Monitor Mask Inc. is a medical device company based in Seattle, Washington, that specializes in manufacturing and selling face mask solutions for CO2 sampling in sidestream capnography during sedation anesthesia. Founded in 2012, the company primarily serves hospitals, ambulatory surgery centers, operating rooms, emergency departments, post-anesthesia care units, intensive care units, emergency medical services, and catheterization laboratories. Its flagship product, the M1 Capnography Mask, inspired the CapnoVue face mask series, which is designed to enhance patient safety by monitoring carbon dioxide levels in a patient's breath. The masks feature pre-formed ports that allow for accurate assessment of oxygen supply, thereby enabling clinicians to improve patient safety and streamline care workflows. Monitor Mask operates as a subsidiary of Salter Labs Inc.

WhiteSpace Health

Seed Round in 2015
WhiteSpace Health, Inc. specializes in data analytics and cloud-based healthcare intelligence solutions for healthcare providers. The company offers a comprehensive business management system that includes tools for measuring physician performance, enhancing operational efficiencies, and improving financial metrics. Their solutions enable healthcare organizations to track and improve utilization, cycle times, quality, safety, and compliance with regulatory requirements. By leveraging a cloud-based visual data analytics platform, WhiteSpace Health converts diverse data points into actionable key performance indicators, allowing providers to respond effectively to the evolving healthcare landscape and consumer demands. Founded in 2014, the company is headquartered in Durham, North Carolina, with additional operations in Seattle, Washington, and a development facility in Hyderabad, India. As of March 2017, WhiteSpace Health operates as a subsidiary of Omega Healthcare Management Services Private Limited.

Tectonic

Series A in 2015
Tectonic Audio Labs Inc. designs and manufactures innovative loudspeakers tailored for various applications, including audiovisual rentals, touring, and religious settings. The company specializes in flat-panel loudspeakers, offering models such as the PL-11 for small to medium venues and the PL-12 for larger spaces. In addition to loudspeakers, Tectonic provides rigging systems, mounting solutions, and speaker cases, catering to markets like clubs, theaters, churches, auditoriums, corporate events, sports venues, and festivals. Utilizing patented technologies, such as distributed mode loudspeakers and balanced mode radiators, Tectonic's products deliver high-quality audio experiences. Founded in 2011 and headquartered in Woodinville, Washington, the company sells its products primarily through dealers in the United States.

Tilting Motor Works

Series A in 2015
Tilting Motor Works, Inc. specializes in developing leaning three-wheel conversion solutions for motorcycles, enhancing their stability and safety without compromising performance. Founded in 2008 and headquartered in Snohomish, Washington, the company replaces the front fork and wheel of traditional motorcycles with a new front end that integrates various components, including shocks, wheels, tires, brakes, and hydraulic systems. This patented retrofit aims to provide riders with an improved riding experience by offering higher performance and increased confidence on the road. With a focus on safety and stability, Tilting Motor Works continues to innovate in the motorcycle modification industry.

LumiThera

Series A in 2015
LumiThera, Inc. is a medical device company dedicated to developing innovative treatment solutions aimed at improving visual function and preventing vision loss associated with debilitating eye diseases. Founded in 2013 and based in Poulsbo, Washington, the company specializes in photobiomodulation therapy, utilizing non-invasive light-emitting diodes (LEDs) and laser treatments to address both acute and chronic ocular disorders. Its flagship product, The Valeda, is designed specifically for the treatment of dry age-related macular degeneration (AMD) and other ocular conditions. LumiThera's technology not only strives to halt or slow the progression of vision-threatening diseases but also aims to enhance visual acuity and contrast sensitivity in patients. Through its advancements in light therapy, LumiThera supports healthcare providers in offering improved treatment options for individuals affected by these common eye disorders.

Precision Image Analysis

Series B in 2015
Precision Image Analysis, Inc., based in Kirkland, Washington, specializes in cloud-based remote medical image post-processing and analysis services for diagnostic medical studies, particularly in CT and MRI imaging. Founded in 2012, the company serves healthcare institutions, universities, and research organizations, providing timely analysis that can be delivered in as little as two hours. Its HIPAA-compliant platform allows users to upload images and monitor their analyses remotely, ensuring efficient workflow and standardized reporting. Precision Image Analysis offers particular expertise in cardiac, vascular, and neuro imaging, allowing healthcare providers to manage image analysis tasks without the need for additional staffing or extensive training on new technology. This capability enables clients to scale their image analysis efforts flexibly and cost-effectively, addressing fluctuations in demand without compromising on quality or efficiency.

Minetta Brook

Series A in 2015
Minetta Brook Inc. is a software development company that creates products and platforms designed to help users efficiently navigate, discover, and track relevant information from extensive datasets. Founded in 2011 and headquartered in Kirkland, Washington, the company leverages patent-pending machine learning and linguistics technology to process both unstructured and structured data. This technology is applicable to a variety of information sources, including streaming news, enterprise document repositories, and social media content. One of its notable offerings is Knewsapp, a real-time news analytics application that provides investment professionals with timely insights by utilizing Bloomberg news and market data. Through its innovative solutions, Minetta Brook aims to facilitate comprehensive data analysis and informed decision-making for its users.

OtoNexus Medical Technologies

Private Equity Round in 2015
OtoNexus Medical Technologies Inc. specializes in the design, development, and commercialization of a patented ultrasound medical device aimed at diagnosing middle ear infections, also known as otitis media, in both children and adults. This innovative device provides clinicians with the ability to differentiate between viral and bacterial infections, facilitating informed decisions regarding the necessity of antibiotics. By employing ultrasound technology in a novel manner, the device delivers rapid diagnosis in seconds and can be utilized by various healthcare professionals, including physicians and non-physician personnel. Additionally, the incorporation of one-use-per-patient tips generates a recurring revenue stream for the company. Founded in 2010 and based in Seattle, Washington, OtoNexus Medical Technologies was previously known as OtoMetrix Medical Technologies before rebranding in July 2014.

Kineta

Venture Round in 2015
Kineta, Inc. is a clinical stage biotechnology company based in Seattle, Washington, focused on the development of immunology-based therapeutics for oncology, neuroscience, and virology. The company is advancing a range of innovative therapies, including KCP-506, a non-opioid antagonist for chronic pain, and LHF-535, an oral antiviral targeting Lassa and other arenaviruses by inhibiting viral entry and replication. Kineta is also engaged in developing next-generation immunotherapies, exemplified by KVA12.1, a VISTA blocking immunotherapy designed to reprogram the immune system to combat cancer. With strategic partnerships with notable organizations like Pfizer and Genentech, Kineta aims to leverage its expertise in antiviral therapies and immune modulation to address significant medical challenges. Formerly known as Lecura, Inc., the company was founded in 2007.

Overlake Capital

Venture Round in 2015
Overlake Capital is an asset management firm founded in 2007, initially emerging from a commitment to achieve superior investment results and challenge conventional approaches. Originally established as Empower, the firm transitioned to the Overlake name in 2014 to honor its dedication to the local Seattle-Bellevue community and its investors. Overlake Capital specializes in offering diverse and high-yield investment services to both institutional and individual clients. The firm tailors its investment solutions to meet the specific goals and needs of each client, emphasizing a client-centric approach. Partners at Overlake work closely with clients to ensure the development and realization of relevant investment objectives, while continually seeking to enhance their services and outcomes.

NuvoMed

Series A in 2015
NuvoMed is a medical device company based in Seattle, Washington, founded in 2012. It specializes in the development of a patented disposable device known as the DisImpactorTM, designed to provide safe, efficient relief for fecal impaction. This innovative device enhances the treatment process by combining enema solution infusion with physical extraction, allowing caregivers to address fecal impaction swiftly while minimizing pain for the patient. By focusing on improving the experience for both patients and healthcare providers, NuvoMed aims to transform an unpleasant medical procedure into a more comfortable and effective solution.

Pyatt Broadmark

Venture Round in 2015
Pyatt Broadmark Management is based in Seattle and offers private loans for real estate financing in Washington, Oregon and Idaho. Pyatt Broadmark Management has proven to be a valuable resource for builders, ‘fix and flip’ investment buyers and developers who require quick closings, “outside the box thinking” and the utmost professional service. At Pyatt Broadmark Management, they develop trust with their borrowers based on communication, careful underwriting and fair pricing. That is why they experience so much repeat business and long-term relationships with borrowers. Whether financing single-family homes, tracts of homes or commercial real estate, their experience and personal approach allow us to respond quickly to client needs, and resolve the issues that inevitably arise in real estate development. From initial financing through project completion, Pyatt Broadmark works alongside clients to ensure their success. Whether negotiating with a third-party lender, ensuring adequate reserves for maintenance and repairs, or addressing environmental concerns, they will be your advocate throughout the process.

KPI Therapeutics

Series A in 2015
KPI Therapeutics, Inc. is a biotechnology company specializing in the development of therapies for unmet medical needs, particularly in the fields of autoimmunity and chronic pain. The company offers several drug candidates, including dalazatide, KPI-150, and KPI-190, targeting systemic autoimmune diseases such as lupus, as well as a CSP conopeptide aimed at managing chronic pain. Founded in 2013 and based in Seattle, Washington, KPI Therapeutics collaborates with various partners, including Kineta, Inc., Chimera Biotec, and the University of Washington School of Medicine, to enhance drug development and improve access to new treatments. The company is committed to accelerating the progression of promising drug candidates through critical stages of development, addressing significant gaps in patient care.

PebbleBee

Venture Round in 2015
Pebblebee, founded in 2013 and based in Seattle, Washington, specializes in trackable technologies for both consumers and enterprises. The company develops smart tracking devices designed to monitor valuable items, providing users with peace of mind. Pebblebee's products are characterized by their long battery life and ease of attachment to various belongings, allowing individuals and businesses to efficiently track their possessions.

PetHub

Venture Round in 2014
PetHub, Inc. specializes in digital pet identification solutions, primarily through its innovative tags and collars designed to reunite lost pets with their owners. Founded in 2010 and headquartered in Wenatchee, Washington, the company offers accessories such as tag connectors and silencers alongside its core products. PetHub’s digital tags leverage smartphone technology, allowing individuals to scan the tag and access the pet's profile, which includes vital information like care instructions and medical conditions. The service boasts a high success rate, with 98% of lost animals returning home without entering shelters, and 96% of them being reunited within 24 hours. PetHub's unique approach also includes instant alerts to owners when their pets are found and the ability to send electronic lost pet posters to local shelters. With a significant market of pet owners in the U.S., PetHub has been recognized for its innovation and effectiveness in pet safety solutions.

Cardiac Insight

Venture Round in 2014
Cardiac Insight Inc. is a privately-held medical device company based in Bellevue, Washington, focused on developing advanced body-worn sensing and computing technologies for diagnostic testing in cardiology, respiratory conditions, and other complex diseases. Founded in 2008, the company is known for its flagship product, CardeaScreen, an electrocardiographic device that measures and records the heart's electrical activity. This device assists physicians during pre-participation exams to identify athletes with abnormal heart conditions. Cardiac Insight's innovations are designed with both physicians and patients in mind, aiming to provide complete solutions to unmet clinical needs rather than merely incremental improvements. The company employs advanced algorithms and software to enhance diagnostic and treatment processes, catering to a diverse clientele that includes pediatricians, primary care physicians, cardiologists, sports team physicians, professional trainers, and community screening organizations.

Varidi

Venture Round in 2014
Varidi, Inc. is a company that specializes in a cloud-based payment platform aimed at helping businesses offer flexible financing options directly to consumers. Founded in 2013 and headquartered in Woodinville, Washington, Varidi's platform provides a comprehensive suite of payment and cash flow solutions, allowing businesses to streamline payment processes through e-invoicing, pay-now, and pay-overtime options. This system not only simplifies the management of payment plans with automated invoicing but also reduces administrative burdens, thereby lowering overhead costs and minimizing bad debt. By enabling businesses to offer diverse payment options, Varidi supports increased revenue generation and customer loyalty.

U Grok It

Venture Round in 2014
U Grok It, Inc. specializes in developing a smartphone-based radio-frequency identification (RFID) solution, which includes a hardware device that connects to iOS and Android devices, a supporting application, and a cloud-based backend. This platform allows users to identify, track, and manage physical objects efficiently, enabling inventory management and item location through mobile technology. U Grok It’s solution is particularly valuable in the context of the Internet of Things, as it facilitates the digitization and connectivity of the physical world. The company provides a robust software development kit that empowers developers to incorporate RFID functionality into their applications. Founded in 2011, U Grok It operates from Steamboat Springs, Colorado, with additional offices in San Francisco and Seattle, distributing its products through authorized resellers.

Minetta Brook

Seed Round in 2013
Minetta Brook Inc. is a software development company that creates products and platforms designed to help users efficiently navigate, discover, and track relevant information from extensive datasets. Founded in 2011 and headquartered in Kirkland, Washington, the company leverages patent-pending machine learning and linguistics technology to process both unstructured and structured data. This technology is applicable to a variety of information sources, including streaming news, enterprise document repositories, and social media content. One of its notable offerings is Knewsapp, a real-time news analytics application that provides investment professionals with timely insights by utilizing Bloomberg news and market data. Through its innovative solutions, Minetta Brook aims to facilitate comprehensive data analysis and informed decision-making for its users.

OraHealth

Venture Round in 2013
Orahealth Corp. develops products for the treatment and prevention of diseases and ailments of the mouth. It offers XyliMelts for dry mouth; CankerMelts for the treatment of canker sores; and Avamin Melts, a mouth lining. The company provides its products through retail and online locations. Orahealth Corp. was incorporated in 2001 and is based in Bellevue, Washington.

SkyKick

Venture Round in 2012
SkyKick, Inc. is a provider of cloud-based migration solutions aimed at assisting IT consultants, system integrators, managed service providers, and value-added resellers in transitioning enterprise customers to the cloud. Founded in 2011 and based in Seattle, Washington, the company offers a suite of applications designed to streamline cloud migration processes. Key offerings include Web Planner, which facilitates sales assessment and planning; Migration Manager, which oversees migration projects; and Cloud Manager, an automation and management tool. SkyKick's software automates Microsoft Office 365 migrations, data backups, and service management, helping IT partners enhance operational efficiency and expand service offerings. The company’s technology also includes tools for managing email, calendar, and contacts during migrations, ensuring a smooth transition for clients.

Vega Performance Marketing

Venture Round in 2012
Vega Performance Marketing, Inc. is a digital media services agency and affiliate marketing network that specializes in cost-per-action (CPA) marketing. Established in 2007 and headquartered in Seattle, Washington, the company offers a range of managed services that include performance marketing programs, technology infrastructure, and campaign management. Vega Performance Marketing collaborates with a global community of online media partners and direct response marketers to deliver optimized marketing solutions for client advertisers, which include agencies and other marketing service providers. The firm has developed partnerships with notable entities and provides direct distribution through various media channels, enhancing its service offerings in the competitive landscape of digital marketing.

AdSpore

Seed Round in 2012
AdSpore operates a smartphone application that provides users access to digital coupons across the University of Washington campus. The application utilizes a gaming format that encourages users to locate and collect "spores," which represent discounts, rebates, and prizes. By engaging with the application, students can discover promotional offers from local businesses in an interactive manner. This platform not only enhances the shopping experience for users but also serves as a cost-effective marketing channel for businesses, facilitating connections through promotions, events, and other communications.

Cadence Biomedical

Series A in 2012
Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

Cadence Biomedical

Venture Round in 2012
Cadence Biomedical, based in Seattle, Washington, specializes in manufacturing medical devices aimed at restoring walking abilities for individuals with mobility impairments. The company’s flagship product, Kickstart, is a neurorehabilitation device designed to facilitate walking recovery for patients suffering from conditions such as stroke, spinal cord injuries, and multiple sclerosis. Utilizing Exotendon technology, which acts like an artificial tendon, Kickstart provides essential support, stability, and swing assistance, making it suitable for both outpatient therapy and home use. Cadence Biomedical was incorporated in 2007 and initially operated under the name Empowering Engineering Technologies, Corp. The company is also developing a new class of device known as a kinetic orthosis, originating from technology invented at the Cleveland Clinic. This innovative approach aims to further enhance mobility for individuals with severe impairments.

iCap Equity

Venture Round in 2012
iCap Equity, LLC is a real estate investment firm based in Bellevue, Washington, specializing in equity investment and lending for real estate projects. Founded in 2011, the firm focuses on providing investment capital to real estate developers, facilitating access to business loans and funding that complement primary debt financing sources. By connecting accredited investors with experienced builders, iCap Equity enables the realization of real estate deals that might not otherwise occur. The firm prides itself on its history of successful investments and partnerships, emphasizing careful project vetting to ensure profitable outcomes for all parties involved.

Pyatt Broadmark

Venture Round in 2012
Pyatt Broadmark Management is based in Seattle and offers private loans for real estate financing in Washington, Oregon and Idaho. Pyatt Broadmark Management has proven to be a valuable resource for builders, ‘fix and flip’ investment buyers and developers who require quick closings, “outside the box thinking” and the utmost professional service. At Pyatt Broadmark Management, they develop trust with their borrowers based on communication, careful underwriting and fair pricing. That is why they experience so much repeat business and long-term relationships with borrowers. Whether financing single-family homes, tracts of homes or commercial real estate, their experience and personal approach allow us to respond quickly to client needs, and resolve the issues that inevitably arise in real estate development. From initial financing through project completion, Pyatt Broadmark works alongside clients to ensure their success. Whether negotiating with a third-party lender, ensuring adequate reserves for maintenance and repairs, or addressing environmental concerns, they will be your advocate throughout the process.

Valant Medical Solutions

Venture Round in 2012
Valant Medical Solutions Inc. offers a web-based electronic health record (EHR) and billing system specifically designed for behavioral health professionals, including psychiatrists, psychologists, and therapists in the United States. Founded in 2005 and based in Seattle, the company provides a comprehensive platform that includes tools for scheduling patient visits, customizing documents, and generating practice management reports. Key features of Valant's system include a Mobile Notes tool for point-of-care documentation, a Patient Portal for patient engagement, and Easy Billing software for efficient electronic billing. Additionally, the platform offers automatic appointment reminders and an electronic prescription module to streamline prescription management. By leveraging cloud technology, Valant aims to enhance administrative and clinical efficiency for its clients, enabling them to focus on improving patient outcomes.

Atossa Therapeutics

Venture Round in 2011
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Seattle, Washington, specializing in the development of innovative treatments for breast health conditions and oncology. The company focuses on addressing unmet medical needs, particularly in breast cancer, through its lead program, Endoxifen, an active metabolite of tamoxifen, which is currently undergoing Phase II studies for prevention and treatment. In addition to Endoxifen, Atossa is developing advanced intraductal microcatheter technology aimed at delivering therapies such as fulvestrant and immunotherapies directly to breast cancer sites. Moreover, Atossa is exploring treatments for COVID-19, including AT-H201, designed to improve lung function in hospitalized patients, and AT-301, a nasal spray intended for at-home use in COVID-19 patients. Originally founded as Atossa Genetics Inc. in 2009, the company rebranded to Atossa Therapeutics, Inc. in January 2020.

NanoICE

Venture Round in 2010
NanoICE, Inc. specializes in the design and manufacture of advanced ice production machines, salt-water dosing systems, and ice storage tanks. The company has developed Molecular Ice Technology, which creates microscopic ice particles from salt water to enhance the preservation of fresh products. This innovative technology serves various sectors, including food producers, transporters, storage companies, retail grocers, restaurants, and hotels, addressing modern challenges related to food preservation. NanoICE aims to achieve three main objectives: preserving natural resource yields to maximize market products, reducing the risk of foodborne illnesses without the need for chemicals, and promoting sustainable practices through partnerships with industry stakeholders. Founded in 2010 and based in Tukwila, Washington, NanoICE distributes its products through a network of distributors.

Enroute Systems

Series A in 2009
Enroute Systems Corporation is a transportation management system company that offers Software-as-a-Service (SaaS) solutions for multi-carrier shipping. Founded in 2008 and based in Seattle, Washington, the company provides tools such as the Enroute Portal, which optimizes shipment execution for a range of shippers, and the Enroute Platform, an XML-based service that enables application access to its functionalities. Additionally, Enroute Systems offers services like Enroute InStore, which assists retail staff in fulfilling web orders and transferring products, and Enroute Inbound, which facilitates shipments from vendors to retail locations. The company's Enroute Analytics tool enhances supply chain visibility by converting shipping data into actionable insights. Enroute Systems is recognized for its capabilities in shipment management, including rules-based carrier selection, label creation, and shipment tracking, making it a valuable partner for online retailers.

Clarity Health Services

Venture Round in 2009
Clarity Health Services Inc. offers an insurance authorization and referral management solution tailored for healthcare practices, hospitals, health systems, and technology partners across the United States. Founded in 2007 and based in Seattle, Washington, the company specializes in care coordination services that facilitate effective management of care transitions, including emergency department discharges. Clarity Health's platform allows users to enhance their service offerings, improve patient care quality, and streamline referral processes. The solution supports radiologists in capturing referrals, enables hospitals and health systems to communicate effectively, and assists Accountable Care Organizations (ACOs) and Independent Practice Associations (IPAs) in coordinating care electronically. This approach allows healthcare providers to quickly realize the benefits of care coordination without the need for extensive investments in proprietary technology. Clarity Health Services operates as a subsidiary of SCI Solutions, Inc. as of November 2015.

Delve Networks

Venture Round in 2009
Delve Networks, founded by Alex Castro in Seattle, is an online video platform specializing in video publishing and search services. The company has served over 280 clients, including notable entities such as the NFL, Cleveland Clinic, and Lego, delivering approximately 200 million streams monthly. The platform allows content producers to manage, publish, and monetize high-quality video content, providing essential features like video hosting, encoding, content delivery, management, metrics, and advertising. In 2010, Delve Networks was acquired by Limelight Networks, becoming a business unit within Limelight while maintaining its Seattle base. Under Castro's leadership, the Delve unit experienced significant growth in customer base and revenue. Delve's team includes experienced professionals from leading tech companies such as Amazon and Yahoo, enhancing its capability in delivering next-generation Internet television services.

Onehub

Venture Round in 2009
Onehub Inc. specializes in providing secure online sharing and collaboration solutions tailored for small and medium-sized businesses. Founded in 2007 and based in Seattle, Washington, the company offers a cloud-based file storage and sharing service that features customizable storage spaces, granular sharing permissions, and collaborative tools such as task assignments and comments. This service allows users to easily organize, store, and share files across various devices, including iPhones, iPads, and Android devices. In addition to its primary service, Onehub also provides Marshal, a free data loss prevention tool that helps businesses identify exposed sensitive data threats within their cloud accounts. With over 1.6 million business users relying on its services, Onehub aims to equip organizations with effective tools for managing and securing their data.

Healionics

Series B in 2008
Healionics Corporation, founded in 2007 and based in Seattle, Washington, specializes in the development and manufacturing of synthetic biomaterials and implantable medical devices aimed at improving healthcare for kidney failure patients. The company has created STARport HD, an implantable device that enables needle-free access to the bloodstream for hemodialysis, and STARgraft, a synthetic vascular graft designed to maintain long-term blood flow without frequent interventions. Healionics' innovations address critical challenges in dialysis treatment, particularly the unreliability of current vascular access methods, which can lead to costly complications. Their STAR biomaterial technology enhances the performance of medical implants by reducing infection and scar tissue formation. Healionics is preparing to initiate human studies for its products, with a focus on improving patient outcomes and reducing overall treatment costs in the dialysis sector.

Chelsey Henry

Series B in 2006
Chelsey Henry, Inc. is a Seattle-based company that specializes in designing and marketing a variety of fashionable and functional handbags and accessories for modern women. Founded in 2004 by Chelsey and Henry, the company aims to support women with mobile lifestyles through its diverse product offerings, which include handbags, laptop bags, travel bags, and totes. Chelsey Henry emphasizes the importance of a woman's handbag as an essential part of her identity, encapsulated in the tagline "My Life's in My Bag." In 2010, the brand was acquired by Chelsey Henry Holdings, LLC, and continues to innovate under the creative direction of Seattle designer Tara Sauvage, who also contributes to the upscale Italian leather line, Rocco e Dante. The company remains dedicated to empowering women by providing stylish and practical solutions for their everyday needs.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.